INVESTOR RELATIONS

FINANCIAL NEWS (PRESS RELEASES)

FINANCIAL NEWS (PRESS RELEASES)

There are currently no events to display.
Date Title
07/11/18
Summary ToggleViewRay's MRIdian Linac Awarded French Tender for MR Image-guided Radiation Therapy

UNICANCER to Bring Next Generation Radiotherapy to Centre Georges-François Leclerc (CGFL) CLEVELAND , July 11, 2018   /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced that the company's MRIdian® Linac has been selected for installation at Centre Georges-François Leclerc (CGFL) in Dijon,

Printer Friendly Version
07/09/18
Summary ToggleLoyola Medicine/Palos Health Installs ViewRay's MRIdian Linac System for MR Image-Guided Radiation Therapy

Chicago-Area Provider Becomes First Community Hospital in the U.S. with ViewRay's Next Generation Linear Accelerator-Based System CLEVELAND , July 9, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Palos Health , in partnership with Loyola Medicine, has installed ViewRay's

Printer Friendly Version
06/21/18
Summary ToggleUniversity of Wisconsin Begins Patient Treatments with ViewRay's MRIdian Linac

Becomes the First Hospital to Upgrade Previous Generation MRIdian to Advanced Linear Accelerator-based System CLEVELAND , June 21, 2018 /PRNewswire/   -- ViewRay, Inc. (Nasdaq: VRAY) announced today that University of Wisconsin Carbone Cancer Center in Madison, Wisconsin , has begun patient

Printer Friendly Version
06/13/18
Summary TogglePioneer of MR Image-Guided Radiotherapy, Washington University, Begins First Clinical Treatments with its Second ViewRay MRIdian System

Next Generation Cancer Therapy Enables Delivery of Higher, Potentially More Effective Radiation Dose Regimens CLEVELAND , June 13, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Printer Friendly Version
06/04/18
Summary ToggleViewRay® to Present at the Jefferies 2018 Global Healthcare Conference

CLEVELAND , June 4, 2018 /PRNewswire/ --  ViewRay, Inc. (NASDAQ: VRAY) announced today that James F. Dempsey , PhD, Founder and Chief Scientific Officer, and Ajay Bansal , Chief Financial Officer, are scheduled to present at the Jefferies 2018 Global Healthcare Conference in New York, NY .

Printer Friendly Version
05/23/18
Summary ToggleWorld-Leading Oncologists to Meet in Miami for Adaptive MR Image-Guided Radiotherapy Symposium

Educational Event Aims to Share Clinical Expertise and Best Practices in MR Image-guided Radiation Therapy CLEVELAND , May 23, 2018 /PRNewswire/ -- Experts in MR image-guided radiation therapy will share their experiences during an educational symposium to be held on Friday, September 28, 2018 in

Printer Friendly Version
05/16/18
Summary ToggleViewRay to Present at the UBS Global Healthcare Conference

CLEVELAND , May 16, 2018 /PRNewswire/ -- ViewRay ® , Inc. (NASDAQ: VRAY) announced today that Chris Raanes , Chief Executive Officer, and Ajay Bansal , Chief Financial Officer, are scheduled to present at the UBS Global Healthcare Conference in New York, NY . Event :                 UBS Global

Printer Friendly Version
05/10/18
Summary ToggleViewRay Reports First Quarter 2018 Financial Results

Reiterates 2018 Financial Guidance CLEVELAND , May 10, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2018 . First Quarter 2018 Highlights: Total revenue of $26.2 million, primarily from 4 revenue units, up from $1.2

Printer Friendly Version
05/07/18
Summary ToggleViewRay Announces Conference Call and Webcast of First Quarter 2018 Financial Results to be Held After Market on May 10, 2018

CLEVELAND , May 7, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2018 financial results, which will take place on Thursday, May 10, 2018 after market. ViewRay will hold a conference call on Thursday, May 10, 2018 at 4:30 p.m.

Printer Friendly Version
05/02/18
Summary ToggleViewRay's Clinical Cooperative Think Tank Convenes to Discuss Clinical Experience and Further Trial Development for MRIdian MR-Image Guided Radiotherapy MRIdian On-Table Adaptive Therapy a Focal Point at the European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting CLEVELAND , May 2, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that members of its Clinical Cooperative Think Tank (C2T2) gathered last week in Printer Friendly Version
04/30/18
Summary ToggleMiami Cancer Institute at Baptist Health South Florida Becomes Second Institution in the United States to Treat Patients with ViewRay's MRIdian® Linac

Novel MR Image-Guided Radiotherapy Enables High-Definition Tumor Visualization and On-table Adaptive Cancer Treatment CLEVELAND , April 30, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Miami Cancer Institute at Baptist Health South Florida has begun patient treatments

Printer Friendly Version
04/19/18
Summary ToggleVU University Medical Center in Amsterdam Delivers First Ever Linear Accelerator-Based On-Table Adaptive MR Image-Guided Radiotherapy Treatment on ViewRay MRIdian® Linac

Two Prestigious Centers in Europe Start Treating Patients with MRIdian® Linac CLEVELAND , April 19, 2018   /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that VU University Medical Center (VUmc) in Amsterdam has begun patient treatments using the Company's next generation system,

Printer Friendly Version
04/18/18
Summary ToggleViewRay Unveils New Soft Tissue Visualization Technologies to Further Advance MR Image-Guided Radiotherapy

New MR Pulse Sequences and Imaging Enhancements Expected to Provide Cutting-Edge Tumor and Healthy Tissue Visualization* CLEVELAND , April 18, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today new MR imaging technologies under development for its MRIdian ® Linac radiotherapy system.

Printer Friendly Version
04/04/18
Summary ToggleUniversity Clinic Heidelberg Completes Installation and Commissioning of ViewRay's MRIdian MR Image-Guided Radiotherapy Linac

MR-Image Guided Linac Treatments in Europe to Commence by Mid-April CLEVELAND , April 4, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the University Clinic Heidelberg in Germany has completed installation and commissioning of the hospital's new MRIdian Linac, the

Printer Friendly Version
03/27/18
Summary ToggleViewRay Surpasses 50th Order for MRIdian® System for Precision Cancer Treatment

Milestone Demonstrates Rapid Adoption of Next-Generation MR-Image Guided Radiation Therapy CLEVELAND , March 27, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced that the company surpassed its 50 th MRIdian MR image-guided radiation therapy system order during the first quarter of 2018 -

Printer Friendly Version
03/16/18
Summary ToggleNearly 200 Oncology Experts Gather to Discuss Advanced Applications of MR Image-Guided Radiotherapy Educational Event Featured Presentations from Five MRIdian® Users Highlighting MR Image-guided Radiation Therapy Clinical Experience and Best Practices CLEVELAND , March 16, 2018 /PRNewswire/ -- Experts in MR image-guided radiation therapy convened today to discuss MR image-guided radiation therapy Printer Friendly Version
03/15/18
Summary ToggleViewRay's MRIdian MR Image-Guided Radiotherapy Linac Receives Japanese Regulatory Approval (Shonin) Clearance Expected to Accelerate Market Adoption of Next-Generation Cancer Care CLEVELAND , March 15, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the MRIdian Printer Friendly Version
03/14/18
Summary ToggleViewRay Finalizes Order for MR Image-Guided Radiation Therapy System at University Hospital Zurich Oncologists at Leading Swiss Hospital Select MRIdian Linac as Preferred Technology In Competitive European Tender CLEVELAND , March 14, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today an order for the company's MRIdian® MR image-guided linac at the University Hospital Zurich Printer Friendly Version
03/12/18
Summary ToggleViewRay Reports Fourth Quarter and Full Year 2017 Financial Results Achieved Record Levels of Revenue, Gross Orders and Backlog for Fourth Quarter and Full Year Introduces 2018 Revenue Guidance of $80-$90 Million CLEVELAND , March 12, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the fourth quarter and full year ended Printer Friendly Version
03/06/18
Summary ToggleViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year 2017 Financial Results to be Held on March 12, 2018 CLEVELAND , March 6, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2017 financial results, which will take place on Monday, March 12, 2018 before market open. ViewRay will hold a conference call on Monday, Printer Friendly Version
02/27/18
Summary ToggleViewRay® to Participate in Upcoming Conferences CLEVELAND , Feb. 27, 2018 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes , Chief Executive Officer, and Ajay Bansal , Chief Financial Officer, are scheduled to participate in two upcoming investor conferences. The first conference is the 2018 BTIG Healthcare Printer Friendly Version
02/26/18
Summary ToggleViewRay Announces $59 Million Equity Financing Financing to Further Support Growth of MRIdian Linac CLEVELAND , Feb. 26, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY), makers of the world's first and only clinical MRI-guided radiation therapy system, announced today that it has entered into an agreement to sell its common stock and Printer Friendly Version
02/07/18
Summary ToggleViewRay Appoints Scott Huennekens and Daniel Moore to its Board of Directors New Directors Bring Extensive Medical Device Experience to the Board CLEVELAND , Feb. 7, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the world's first and only clinical MRI-guided radiation therapy system, announced today the appointment of medical device industry veterans Scott Printer Friendly Version
01/08/18
Summary ToggleViewRay Announces Preliminary Fourth Quarter and Fiscal Year 2017 Results CLEVELAND , Jan. 8, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2017 . The preliminary results reported have not been audited and are subject to change. Printer Friendly Version
ViewRay

ViewRay Headquarters

2 Thermo Fisher Way
Oakwood Village, Ohio 44146 +1 (440) 703-3210
info@viewray.com